226 related articles for article (PubMed ID: 29254156)
1. The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients.
Li J; Li B; Ren C; Chen Y; Guo X; Zhou L; Peng Z; Tang Y; Chen Y; Liu W; Zhu B; Wang L; Liu X; Shi X; Peng Z
Oncotarget; 2017 Nov; 8(60):101189-101202. PubMed ID: 29254156
[TBL] [Abstract][Full Text] [Related]
2. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Peng Z; Tang Y; Liu W; Zhu B; Wang L; Ren C
J Cell Mol Med; 2017 May; 21(5):838-847. PubMed ID: 28233416
[TBL] [Abstract][Full Text] [Related]
3. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
Yan S; Han B; Gao S; Wang X; Wang Z; Wang F; Zhang J; Xu D; Sun B
Oncotarget; 2017 Sep; 8(36):60149-60158. PubMed ID: 28947960
[TBL] [Abstract][Full Text] [Related]
4. Exosome-transmitted miRNA-335-5p promotes colorectal cancer invasion and metastasis by facilitating EMT via targeting RASA1.
Sun X; Lin F; Sun W; Zhu W; Fang D; Luo L; Li S; Zhang W; Jiang L
Mol Ther Nucleic Acids; 2021 Jun; 24():164-174. PubMed ID: 33767913
[TBL] [Abstract][Full Text] [Related]
5. The mechanisms underlying the enrichment and action of glypican-1-positive exosomes in colorectal cancer cells.
Li J; Chen Y; Yu S; Liao M; Zhou L; Jia Z; Tang Y; Yuan B
Transl Oncol; 2023 Jun; 32():101655. PubMed ID: 36963204
[TBL] [Abstract][Full Text] [Related]
6. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.
Chang TY; Tsai WC; Huang TS; Su SH; Chang CY; Ma HY; Wu CH; Yang CY; Lin CH; Huang PH; Cheng CC; Cheng SM; Wang HW
PLoS One; 2017; 12(7):e0181562. PubMed ID: 28727754
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
12.
Zhang M; Wang Y; Yu L; Zhang Y; Wang Y; Shang Z; Xin Y; Li X; Ning N; Zhang Y; Zhang X
iScience; 2023 Sep; 26(9):107686. PubMed ID: 37694140
[No Abstract] [Full Text] [Related]
13. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
14. Screening of exosomal microRNAs from colorectal cancer cells.
Clancy C; Khan S; Glynn CL; Holian E; Dockery P; Lalor P; Brown JA; Joyce MR; Kerin MJ; Dwyer RM
Cancer Biomark; 2016; 17(4):427-435. PubMed ID: 27802194
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer.
Yue B; Sun B; Liu C; Zhao S; Zhang D; Yu F; Yan D
Cancer Sci; 2015 Oct; 106(10):1323-32. PubMed ID: 26224446
[TBL] [Abstract][Full Text] [Related]
16. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway.
Lu D; Yao Q; Zhan C; Le-Meng Z; Liu H; Cai Y; Tu C; Li X; Zou Y; Zhang S
Oncotarget; 2017 Apr; 8(14):22674-22684. PubMed ID: 28186967
[TBL] [Abstract][Full Text] [Related]
18. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
19. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
20. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
